The U.S. Drug Enforcement Administration (DEA) has reaffirmed that no deaths from marijuana overdose have been reported, highlighting a distinction between cannabis and other controlled substances as federal policies surrounding marijuana continue to evolve.
The statement appears in the agency’s updated 2026 Drugs of Abuse publication, a 119-page report examining controlled substances and their effects. The document also acknowledges potential risks associated with cannabis consumption, including impaired coordination, changes in perception and an increasing number of emergency room visits involving marijuana edibles.
According to the DEA, cannabis intoxication can affect learning, judgment and psychomotor functions, including the ability to drive safely. Long-term use may also lead to physical dependence, withdrawal symptoms and psychological dependence.
Although fatal overdoses from marijuana have not been reported, health concerns remain. Edible cannabis products can be particularly challenging for inexperienced consumers because their effects may take longer to develop, potentially leading individuals to consume more than intended.
The updated report also reflects changes in the federal government’s approach to medical cannabis. Unlike the previous edition published in 2024, the new version recognizes the expansion of state-regulated medical marijuana programs and incorporates recent federal scheduling changes.
In April 2026, the Department of Justice moved certain qualifying marijuana products, including FDA-approved cannabis medications and products covered by state medical cannabis licensing, into Schedule III of the Controlled Substances Act. A broader federal rescheduling process remains under consideration.
The change represents a significant development in federal drug policy, although it does not amount to nationwide legalization of recreational marijuana.
Cannabis remains subject to restrictions, and its legal status varies depending on federal regulations and individual state laws. The DEA’s report underscores the importance of distinguishing between the absence of reported fatal marijuana overdoses and the substance’s other potential health risks.
As lawmakers and federal agencies continue debating cannabis regulation, the updated publication provides a snapshot of the government’s evolving position. Its findings may inform discussions about public health, medical access and the appropriate classification of marijuana under federal law.
Read the whole article from Marijuanamoment here.
The post “No Deaths From Marijuana Overdose” Stated In New DEA Report appeared first on Weed Deep Dive.
Originally published on Weed Deep Dive.
